secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001213900-25-030089
Event type: litigation
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD files lawsuit against Mayne Pharma for breach of contract over 2022 agreements
--------------------------------------------------------------------------------

- Filed April 8, 2025 in U.S. District Court for Delaware (Case No. not assigned).
- Seeks damages for breach of contract, implied covenant, fraudulent inducement, and unjust enrichment.
- Dispute centers on net working capital allowances under License and Transaction Agreements dated December 4, 2022.
- No specified damages amount; litigation outcome uncertain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000121390025030089/0001213900-25-030089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000121390025030089/ea0237667-8k_therap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-030089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer